Anavex Life Sciences Corp (AVXL)
4.12
-0.01
(-0.24%)
USD |
NASDAQ |
Jul 03, 16:00
Anavex Life Sciences Net Income (Annual): -47.50M for Sept. 30, 2023
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| September 30, 2023 | -47.50M |
| September 30, 2022 | -47.98M |
| September 30, 2021 | -37.91M |
| September 30, 2020 | -26.28M |
| September 30, 2019 | -26.30M |
| September 30, 2018 | -17.25M |
| September 30, 2017 | -13.46M |
| September 30, 2016 | -14.74M |
| September 30, 2015 | -12.11M |
| September 30, 2014 | -9.968M |
| Date | Value |
|---|---|
| September 30, 2013 | -3.70M |
| September 30, 2012 | -8.302M |
| September 30, 2011 | -7.307M |
| September 30, 2010 | -8.783M |
| September 30, 2009 | -5.499M |
| September 30, 2008 | -5.351M |
| September 30, 2007 | -1.58M |
| September 30, 2006 | -0.0255M |
| September 30, 2005 | -0.0916M |
| September 30, 2004 | -0.0144M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Annual) Range, Past 5 Years
-47.98M
Minimum
2022
-26.28M
Maximum
2020
-37.19M
Average
-37.91M
Median
2021
Net Income (Annual) Benchmarks
| Ventyx Biosciences Inc | -192.96M |
| Checkpoint Therapeutics Inc | -51.85M |
| Biogen Inc | 1.161B |
| Amicus Therapeutics Inc | -151.58M |
| InfuSystems Holdings Inc | 0.872M |